Investigation of the variability of three types of activated clotting time point-of-care systems in cardiac surgery

Investigation of the variability of three types of activated clotting time point-of-care systems in cardiac surgery - Investigation of the variability of activated clotting time point-of-care systems

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055988

Enrollment

150

Registered

2024-11-16

Start date

2024-11-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac surgery

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients underwent elective cardiovascular surgery under cardio-pulmonary bypass (ACT more than 480 sec) will be assessed.

Exclusion criteria

Exclusion criteria: 1. Patients with significantly decreased coagulation factors, platelets, and albumin, due to sepsis, etc., preoperatively. 2. Emergency surgery. 3. Patients who have refused to participate in this study.

Design outcomes

Primary

Measure	Time frame
Activated clotting time: before heparin injection, 3 minutes after heparin injection, 30 minutes after the start of cardiopulmonary bypass, after protamine injection, before returning to the room	—

Countries

Japan

Contacts

Public ContactYUKI NUMATA

Dokkyo Medical University Department of Anesthesiology

numagene@gmail.com0282-86-1111

Outcome results